Shares of CVS Group plc (LON:CVSG – Get Free Report) have received an average recommendation of “Moderate Buy” from the five research firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is GBX 1,680.
Several research analysts have commented on the company. Shore Capital Group reiterated a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a report on Thursday, September 24th. Jefferies Financial Group reissued a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research report on Friday, September 25th. Deutsche Bank restated a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a research note on Monday, July 27th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, September 24th.
Check Out Our Latest Report on CVS Group
CVS Group Price Performance
LON CVSG opened at GBX 1,398 on Friday. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,432. The company has a debt-to-equity ratio of 110.41, a quick ratio of 0.90 and a current ratio of 1.18. The stock has a market capitalization of £932.40 million, a PE ratio of 57.53, a P/E/G ratio of 1.77 and a beta of 1.04. The stock has a 50-day simple moving average of GBX 1,288.87 and a 200 day simple moving average of GBX 1,256.13.
CVS Group (LON:CVSG – Get Free Report) last announced its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. Research analysts anticipate that CVS Group will post 93.94 EPS for the current year.
About CVS Group
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
See Also
- Five stocks we like better than CVS Group
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
